Abiomed Inc (NASDAQ:ABMD)
| 21.98 Data as of May 24 |  +0.26 / +1.20%Today’s Change | 11.80 Today|||52-Week Range 24.93 | +63.54% Year-to-Date |
Latest ABMD News | Press Releases
| Some Numbers at ABIOMED that Make Your Stock Look Good May 23 / MotleyFool.com |
Today’s Trading
| Previous close | 21.72 |
| Today’s open | 21.72 |
| Day’s range | 21.40 - 22.02 |
| Volume | 339,568 |
| Average volume (3 months) | 462,342 |
| Market cap | $847.5M |
| Dividend yield | -- |
Data as of 4:00pm ET, 05/24/2013
Growth & Valuation
| Earnings growth (last year) | -- |
| Earnings growth (this year) | +768.18% |
| Earnings growth (next 5 years) | +19.50% |
| Revenue growth (last year) | +24.94% |
| P/E ratio | 59.4 |
| Price/Sales | 6.74 |
| Price/Book | 6.83 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| LMNXLuminex Corp | +0.15 | +0.79% |
| TRNXTornier NV | +0.02 | +0.12% |
| VOLCVolcano Corp | +0.27 | +1.56% |
| ARTCArthroCare Corp | +0.06 | +0.18% |
Data as of 4:00pm ET, 05/24/2013
Financials
| Next reporting date | August 8, 2013 |
| EPS forecast (this quarter) | $0.06 |
| Annual revenue (last year) | $126.4M |
| Annual profit (last year) | $1.5M |
| Net profit margin | 1.18% |
Profile
Sector Health Technology |
Industry Medical Specialties |
Chairman, President & Chief Executive Officer Michael R. Minogue, MBA |
Chief Operating Officer David M. Weber, PhD |
Corporate headquarters Danvers, Massachusetts |
Forecasts
